Erin Crown, PA-C: The Difficulty in Treating Schizophrenia

Article

A physician's assistant for Oasis Lifecare discusses some of the new and promissing treatments for schizophrenia.

Schizophrenia remains one of the more difficult psychiatric disorders to treat, largely because of the different symptoms attached to the disease, as well as the negative side effects like weight gain that come with the medications commonly used.

The disease is challenging largely because the symptoms can manifest so differently in individual patients. Some patients become delusional and hallucinate events that are removed from reality, other patients tend to crave social isolation and lack the ability for emotional responses.

Other comorbidities included paranoia, depression, and impaired motor functions.

While antipsychotics can be effective in treating patients with schizophrenia, the treatment themselves come with a number of side effects that cause schizophrenia patients to go off and on medications, depending on how some of the side effects are impacting their everyday lives.

These side effects include nausea, weight gain, dizziness, and blurred vision because antipsychotic medications change the way brain chemicals act in order to treat certain symptoms such as hallucinations or hearing voices.

In an interview with HCPLive®, Erin C. Crown, PA-C, a physician’s assistant for Oasis Lifecare, explained just why schizophrenia is so difficult to treat and what new treatments could be on the horizon to help this patient population.

Recent Videos
Boadie Dunlop, MD, Weighs in on FDA Advisory Vote on Lykos’ MDMA
Bhanu Prakash Kolla, MBBS, MD: Treating Sleep with Psychiatric Illness
Awaiting FDA Decision on MDMA Assisted Therapy, with Bessel van der Kolk, MD
Bessel van der Kolk, MD: The Future of MDMA Assisted Therapy in PTSD
Bessel van der Kolk, MD: What MDMA-Assisted Therapy Taught us About PTSD
Why Are Adult ADHD Cases Climbing?
Getting Black Men Involved in Their Health Care, Clinical Research
Patient Involvement in Advanced HF Treatment, with Ashley Malliett, DMSc, MPAS, PA-C
Aaron Henry, PA-C, MSHS: Regaining Black Male Patient Trust in the Doctor's Office
Depression Screening: Challenges and Solutions at the Primary Care Level
© 2024 MJH Life Sciences

All rights reserved.